Paula Gardiner1, Ekaterina Sadikova2, Amanda C Filippelli2, Laura F White3, Brian W Jack2. 1. Department of Family Medicine, Boston University School of Medicine, Boston Medical Center, Boston, USA. Electronic address: Paula.gardiner@bmc.org. 2. Department of Family Medicine, Boston University School of Medicine, Boston Medical Center, Boston, USA. 3. Department of Biostatistics, Boston University School of Public Health, Boston, USA.
Abstract
OBJECTIVE: To explore inpatient reconciliation of dietary supplement (DS) use and determine characteristics associated with DS documentation. METHODS: We analyzed DS use among 558 inpatients recruited from the Re-Engineered Discharge clinical trial to identify: (1) if patients self-reported DS and (2) if DS use was documented at admission. We examined socio-demographics for association with documentation using chi squares and t-tests. Logistic regression was performed to assess adjusted associations with DS documentation. RESULTS: Sixty percent reported DS use (n=333). Among users, 36% had admission DS documentation, 20% were asked about use at admission, 18% reported disclosing use to a provider, and 48% reported they would continue to use DS. Overall, 6% of participants were asked, disclosed, and had documentation of DS. Logistic regression revealed increased age associated with lower odds of DS documentation. Identifying as Hispanic or African American reduces DS documentation odds compared to those identifying as white. CONCLUSIONS: There is lack of consistent DS medical reconciliation in the inpatient setting. While more than half of patients used DS prior to hospitalization, most were not asked about use on admission. PRACTICE IMPLICATIONS: This study adds to literature on medical reconciliation which requires that providers inquire and document patient DS use.
OBJECTIVE: To explore inpatient reconciliation of dietary supplement (DS) use and determine characteristics associated with DS documentation. METHODS: We analyzed DS use among 558 inpatients recruited from the Re-Engineered Discharge clinical trial to identify: (1) if patients self-reported DS and (2) if DS use was documented at admission. We examined socio-demographics for association with documentation using chi squares and t-tests. Logistic regression was performed to assess adjusted associations with DS documentation. RESULTS: Sixty percent reported DS use (n=333). Among users, 36% had admission DS documentation, 20% were asked about use at admission, 18% reported disclosing use to a provider, and 48% reported they would continue to use DS. Overall, 6% of participants were asked, disclosed, and had documentation of DS. Logistic regression revealed increased age associated with lower odds of DS documentation. Identifying as Hispanic or African American reduces DS documentation odds compared to those identifying as white. CONCLUSIONS: There is lack of consistent DS medical reconciliation in the inpatient setting. While more than half of patients used DS prior to hospitalization, most were not asked about use on admission. PRACTICE IMPLICATIONS: This study adds to literature on medical reconciliation which requires that providers inquire and document patient DS use.
Authors: Paula Gardiner; Russell S Phillips; Kathi J Kemper; Anna Legedza; Silas Henlon; Alan D Woolf Journal: Pediatrics Date: 2008-04 Impact factor: 7.124
Authors: Stephen Shalansky; Larry Lynd; Kathryn Richardson; Andrew Ingaszewski; Charles Kerr Journal: Pharmacotherapy Date: 2007-09 Impact factor: 4.705
Authors: Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau Journal: JAMA Date: 2008-12-24 Impact factor: 56.272
Authors: Andrew I Geller; Nadine Shehab; Nina J Weidle; Maribeth C Lovegrove; Beverly J Wolpert; Babgaleh B Timbo; Robert P Mozersky; Daniel S Budnitz Journal: N Engl J Med Date: 2015-10-15 Impact factor: 91.245
Authors: Daniela L Stan; Dietlind L Wahner-Roedler; Kathleen J Yost; Thomas Jamie O'Byrne; Megan E Branda; Aaron L Leppin; Jon C Tilburt Journal: J Altern Complement Med Date: 2018 Sep/Oct Impact factor: 2.579
Authors: Michael R Gionfriddo; Vanessa Duboski; Allison Middernacht; Melissa S Kern; Jove Graham; Eric A Wright Journal: PLoS One Date: 2021-12-02 Impact factor: 3.240